These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 12421455
1. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus). Natov SN, Pereira BJ. Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455 [Abstract] [Full Text] [Related]
2. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus). Natov SN. Transpl Infect Dis; 2002 Sep; 4(3):124-31. PubMed ID: 12421456 [Abstract] [Full Text] [Related]
7. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients. Wang XD, Feng SJ, Liu JP, Song TR, Huang ZL, Fan Y, Shi YY, Chen LY, Lv YH, Xu ZL, Li XH, Wang L, Lin T. BMC Infect Dis; 2021 Jan 09; 21(1):41. PubMed ID: 33422017 [Abstract] [Full Text] [Related]
8. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F, Bunnapradist S, Martin P. J Nephrol; 2002 Jan 09; 15(6):605-13. PubMed ID: 12495272 [Abstract] [Full Text] [Related]
9. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M, Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups. Transplant Proc; 2005 Mar 09; 37(2):1238-9. PubMed ID: 15848681 [Abstract] [Full Text] [Related]
11. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation. Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A. Biol Blood Marrow Transplant; 2010 Jun 09; 16(6):809-17. PubMed ID: 20060484 [Abstract] [Full Text] [Related]
12. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec 09; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
15. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Nery JR, Nery-Avila C, Reddy KR, Cirocco R, Weppler D, Levi DM, Nishida S, Madariaga J, Kato T, Ruiz P, Schiff E, Tzakis AG. Transplantation; 2003 Apr 27; 75(8):1179-86. PubMed ID: 12717200 [Abstract] [Full Text] [Related]
18. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. Transplantation; 1995 Jan 27; 59(2):230-4. PubMed ID: 7839446 [Abstract] [Full Text] [Related]
19. [Risk of hepatitis B virus transmission from hepatitis B core antibody-positive liver donors]. Bárcena Marugán R, García Garzón S, López San Román A, Peña González E, Nasha R, Férnandez Muñoz R, Mateos M, García Plaza A. Med Clin (Barc); 2001 Feb 03; 116(4):125-8. PubMed ID: 11222157 [Abstract] [Full Text] [Related]
20. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients. Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P. Transplant Proc; 2005 Feb 03; 37(6):2574-5. PubMed ID: 16182748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]